Dry powder inhalers
(DPI) are used to deliver drugs in dry powdered form to the lungs of
patients suffering from respiratory disorders. Pulmonary drug
delivery has been gaining attention and acceptance in the past few
years in the treatment of respiratory disorders due to advantages
such as faster drug absorption, high bioavailability, and local
action of the drug in the respiratory tract, allowing faster
treatment and quick relief to patients suffering from respiratory
disorders. It is usually achieved through three types: nebulizers,
pressurized metered dose inhalers (P-MDI), and dry powder inhalers.
Dry powder inhalers are more preferred over pressurized metered dose
inhalers due to rising environmental concerns regarding chloro-flouro
carbon (CFC) used as a propellant in P-MDIs. This has induced
manufacturers to enter the dry powder inhalers segment, offering a
wide range of products to patients suffering from respiratory
disorders.
The global dry
powder inhalers market can be segmented based on product type,
indication, distribution channel, and region. In terms of product
type, the global market can be categorized into capsule based
devices, blister based devices, reservoir/cartridge based devices,
and others. The capsule based devices segment is expected to dominate
the global dry powder inhalers market during the forecast period,
owing to increase in number of manufacturers offering diverse
products in the segment and rise in adoption and preference of health
care providers and patients for these devices. Based on indication,
the global dry powder inhalers market can be classified into
bronchitis, chronic obstructive pulmonary diseases (COPD), asthma,
and others. The asthma segment accounted for the largest share of the
global market in 2016, owing to increase in air pollution levels
across the world and rise in incidence of asthma especially in
developed countries. In terms of distribution channel, the global
market can be divided into hospital pharmacies, online pharmacies,
retail pharmacies, and drug stores.
Rise in incidence of
respiratory disorders including chronic obstructive pulmonary
diseases (COPD) and asthma, increase in air pollution levels
especially in emerging countries, and surge in per capita health care
spending are the major factors increasing demand and consumption of
dry powder inhalers (DPI) across the globe. However, disadvantages of
dry powder inhalers including increase in patient dependence,
problems in dose uniformity, and higher cost of devices as compared
to pressurized metered dose inhalers (P-MDI) are expected to restrain
the global dry powder inhalers (DPI) market during the forecast
period.
Download Report
Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30638
The global dry
powder inhalers market can be segmented into five major regions:
North America, Europe, Asia Pacific, Latin America, and Middle East &
Africa. According to Centers for Disease Control and Prevention (CDC)
statistics, in 2015, an estimated 18.4 million adults were suffering
from asthma in the U.S. alone. High prevalence of chronic respiratory
diseases including asthma and allergic asthma in the U.S. and
favorable reimbursement policies for dry powder inhalers in the
country are the major factors attributed to North America’s large
and dominant market share in 2016. Countries in Europe such as
Germany, the U.K., Russia, and France also reported higher prevalence
of respiratory diseases including asthma, higher per capita health
care spending, and increase in number of market players introducing
new products in the market. These factors are attributed to Europe’s
significant market share in 2016.
Key players
operating in the global dry powder inhalers market are AstraZeneca,
GlaxoSmithKline plc, Vectura Group plc, Boehringer Ingelheim GmbH,
Otsuka Pharmaceutical Co. Ltd., Norton Healthcare, and Respira
Therapeutics, Inc.
Pre-Book Full
Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=30638<ype=S
About Us
Transparency Market
Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants, use proprietary data sources
and various tools and techniques to gather, and analyze information.
Our business offerings represent the latest and the most reliable
information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated
research report covers a different sector - such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices,
consumer goods and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider
scope and stratified research methodology, TMR’s syndicated reports
strive to provide clients to serve their overall research
requirement.
US Office Contact
90 State Street,
Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment